BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10444803)

  • 1. Metabolic intervention for the ischemic and post-ischemic heart.
    Svedjeholm R; Håkanson E; Szabó Z
    Wien Klin Wochenschr; 1999 Jul; 111(13):501-11. PubMed ID: 10444803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials.
    Schipke JD; Friebe R; Gams E
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):479-85. PubMed ID: 16481185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucose-insulin-potassium (GIK) in prevention and therapy of myocardial ischemia].
    Haider W; Hiesmayr M
    Wien Klin Wochenschr; 2000 Apr; 112(7):310-21. PubMed ID: 10849955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glucose-insulin-potassium (GIK) in the reduction of acute myocardial ischemia after an aortocoronary bypass intervention].
    Dainese L; Polvani GL; Fumero A; Spirito R; Alamanni F; Agrifoglio M; Parolari A; Biglioli P
    G Ital Cardiol; 1999 May; 29(5):575-9; discussion 580-2. PubMed ID: 10367228
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolic support of the ischemic heart during cardiac surgery].
    Luna Ortiz P; Serrano Valdés X; Rojas Pérez E; de Micheli A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S121-36. PubMed ID: 17469340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-insulin-potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms.
    Timmer JR; van der Horst IC; Ottervanger JP; De Luca G; van 't Hof AW; Bilo HJ; Zijlstra F
    Ital Heart J; 2004 Oct; 5(10):727-31. PubMed ID: 15626267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac metabolism in ischemic heart disease.
    Opie LH
    Arch Mal Coeur Vaiss; 1999 Dec; 92(12):1755-60. PubMed ID: 10665328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A challenge to the metabolic approach to myocardial ischaemia.
    Apstein CS; Opie LH
    Eur Heart J; 2005 May; 26(10):956-9. PubMed ID: 15797886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
    Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.
    Sack MN; Yellon DM
    J Am Coll Cardiol; 2003 Apr; 41(8):1404-7. PubMed ID: 12706939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic therapy in cardiac surgery--"Optimizing the engine's fuel supply and more...".
    Doenst T; Amorim PA
    Scand Cardiovasc J; 2010 Feb; 44(1):4-8. PubMed ID: 20141343
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).
    van der Horst IC; Timmer JR; Ottervanger JP; Bilo HJ; Gans RO; de Boer MJ; Zijlstra F;
    Am Heart J; 2005 Apr; 149(4):585-91. PubMed ID: 15990738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs.
    Zhang HX; Zang YM; Huo JH; Liang SJ; Zhang HF; Wang YM; Fan Q; Guo WY; Wang HC; Gao F
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):306-13. PubMed ID: 17204910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis.
    Fan Y; Zhang AM; Xiao YB; Weng YG; Hetzer R
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):192-9. PubMed ID: 21075642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GIK) solutions.
    Lazar HL
    Am J Cardiol; 1997 Aug; 80(3A):90A-93A. PubMed ID: 9293960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model.
    Oates A; Nubani R; Smiley J; Kistler L; Hughey S; Theiss P; Perez-Tamayo RA; Eiferman D; Lonchyna V; Higgins RS
    Surgery; 2009 Jul; 146(1):23-30. PubMed ID: 19541007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glucose-insulin-potassium solution added to reperfusion treatment in acute myocardial infarction.
    Türel B; Gemici K; Baran I; Yeşilbursa D; Güllülü S; Aydinlar A; Serdar A; Kazazoğlu AR; Kumbay E; Cordan J
    Anadolu Kardiyol Derg; 2005 Jun; 5(2):90-4. PubMed ID: 15939681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes.
    Szabó Z; Arnqvist H; Håkanson E; Jorfeldt L; Svedjeholm R
    Clin Sci (Lond); 2001 Jul; 101(1):37-43. PubMed ID: 11410112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial.
    Quinn DW; Pagano D; Bonser RS; Rooney SJ; Graham TR; Wilson IC; Keogh BE; Townend JN; Lewis ME; Nightingale P;
    J Thorac Cardiovasc Surg; 2006 Jan; 131(1):34-42. PubMed ID: 16399292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.